Skip to Content

Avecho Biotechnology Ltd AVEFF

Morningstar Rating
$0.00 0.00 (14.29%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AVEFF is trading at a 158% premium.
Price
$0.00
Fair Value
$6.98
Uncertainty
Extreme
1-Star Price
$4.59
5-Star Price
$7.86
Economic Moat
Ynr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AVEFF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.10
Market Cap
$9.51 Mil
Volume/Avg
320,000 / 320,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.44
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skincare and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
34

Valuation

Metric
AVEFF
Price/Earnings (Normalized)
Price/Book Value
0.15
Price/Sales
1.44
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AVEFF
Quick Ratio
7.83
Current Ratio
8.30
Interest Coverage
Quick Ratio
AVEFF

Profitability

Metric
AVEFF
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
AVEFF
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
VfkdjmpyXjzz$636.2 Bil
Vertex Pharmaceuticals Inc
VRTX
XbmxlqlzBpxfn$126.1 Bil
Regeneron Pharmaceuticals Inc
REGN
NczthjnsYrlprpw$121.2 Bil
Moderna Inc
MRNA
DpkhtttkgLdhvj$46.5 Bil
Alnylam Pharmaceuticals Inc
ALNY
DbrxckmfFcmhq$33.0 Bil
argenx SE ADR
ARGX
ZbgjyjpZrvnh$27.9 Bil
BioNTech SE ADR
BNTX
BfxgtcfqCnrl$20.5 Bil
Biomarin Pharmaceutical Inc
BMRN
SszrzdhkCshbng$16.1 Bil
United Therapeutics Corp
UTHR
FntlwcwmRkx$14.3 Bil
Incyte Corp
INCY
SvfvvfzLrtkq$12.5 Bil

Sponsor Center